Ocular Therapeutix looks to raise $25m in public offering

Ocular Therapeutix (NSDQ:OCUL) said today that it launched a $25 million underwritten public offering of its common stock. The Bedford, Mass.-based company did not provide any specific pricing details for the offering.

Cantor Fitzgerald & Co. is the sole bookrunner for the offering, according to regulatory filings.

Yesterday, the company  said today that it resubmitted a New Drug Application to the FDA for its post-surgical ocular pain reliever.

Get the full story at our sister site, Drug Delivery Business News.

The post Ocular Therapeutix looks to raise $25m in public offering appeared first on MassDevice.

from MassDevice http://ift.tt/2jsKSKc